Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Cancer metabolism

When more is less

A tightly regulated enzyme balances energy production and the synthesis of macromolecules from glucose in cancer cells. Upsetting this balance by stimulating the enzyme's activity can suppress tumour growth in mice.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: A metabolic bottleneck.

References

  1. Anastasiou, D. et al. Nature Chem. Biol. 8, 839–847 (2012).

    Article  CAS  Google Scholar 

  2. Mazurek, S., Boschek, C. B. & Eigenbrodt, E. J. Bioenerg. Biomembr. 29, 315–330 (1997).

    Article  CAS  PubMed  Google Scholar 

  3. Christofk, H. R. et al. Nature 452, 230–233 (2008).

    Article  ADS  CAS  Google Scholar 

  4. Christofk, H. R., Vander Heiden, M. G., Wu, N., Asara, J. M. & Cantley, L. C. Nature 452, 181–186 (2008).

    Article  ADS  CAS  Google Scholar 

  5. Hitosugi, T. et al. Sci. Signal. 2, ra73 (2009).

    Article  PubMed  Google Scholar 

  6. Lu, C. & Thompson, C. B. Cell Metab. 16, 9–17 (2012).

    Article  CAS  PubMed  Google Scholar 

  7. Luo, W. et al. Cell 145, 732–744 (2011).

    Article  CAS  PubMed  Google Scholar 

  8. Vander Heiden, M. G. et al. Biochem. Pharmacol. 79, 1118–1124 (2010).

    Article  CAS  PubMed  Google Scholar 

  9. Goldberg, M. S. & Sharp, P. A. J. Exp. Med. 209, 217–224 (2012).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lei Jiang.

Ethics declarations

Competing interests

L.J. receives salary support from Janssen Pharmaceutica NV, Beerse, Belgium. R.J.D. is a consultant for Agios Pharmaceuticals, Cambridge, Massachusetts, and is on the scientific advisory board of Peloton Therapeutics, Dallas, Texas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jiang, L., DeBerardinis, R. When more is less. Nature 489, 511–512 (2012). https://doi.org/10.1038/489511a

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/489511a

This article is cited by

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer